FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386906001: Capecitabine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461084018 Capecitabine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481020018 Capecitabine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
51001000195115 capecitabina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
797451000172119 capécitabine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
65131000195119 Capecitabin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Capecitabine (substance) Is a Pyrimidine false Inferred relationship Some
Capecitabine (substance) Is a Pyrimidine analog (substance) false Inferred relationship Some
Capecitabine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that competes with, replaces or inhibits a specific metabolite of a cell and thereby interferes with the cell's normal metabolic functioning. true Inferred relationship Some
Capecitabine (substance) Is a Fluoropyrimidine (substance) true Inferred relationship Some
Capecitabine (substance) Is a Enzyme inhibitor false Inferred relationship Some
Capecitabine (substance) Is a Thymidylate synthase inhibitor true Inferred relationship Some
Capecitabine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Thymidylate synthase inhibitor (disposition) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing capecitabine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Capecitabine (substance) Inferred relationship Some 1
Capecitabine 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Capecitabine (substance) Inferred relationship Some
Capecitabine 150 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Capecitabine (substance) Inferred relationship Some
Product containing capecitabine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Capecitabine (substance) Inferred relationship Some 1
Capecitabine overdose (disorder) Causative agent (attribute) True Capecitabine (substance) Inferred relationship Some 1
Capecitabine 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Capecitabine (substance) Inferred relationship Some 1
Capecitabine 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Capecitabine (substance) Inferred relationship Some 1
Capecitabine 150 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Capecitabine (substance) Inferred relationship Some 1
Capecitabine 150 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Capecitabine (substance) Inferred relationship Some 1
Capecitabine 150 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Capecitabine (substance) Inferred relationship Some 1
Capecitabine 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Capecitabine (substance) Inferred relationship Some 1
Product containing only capecitabine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Capecitabine (substance) Inferred relationship Some 1
Capecitabine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Capecitabine (substance) Inferred relationship Some 1
Product containing precisely capecitabine 300 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Capecitabine (substance) Inferred relationship Some 1
Product containing precisely capecitabine 300 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Capecitabine (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start